Idera Pharmaceuticals Inc. (NASDAQ: IDRA) is focused on cancer and rare diseases, and it could be a what traders refer to as a three-bagger or four-bagger, if two analysts who made key calls in recent days end up being correct here. As it has a market cap of just about $370 million, investors need to consider that they likely are taking far greater risk in Idera than with established biotech and....More>>>
Financial Gravity Companies Inc. raised its stake in shares of Grifols (NASDAQ:GRFS) by 264.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 13,862 shares of the biotechnology company’s stock after purchasing an additional 10,054 shares during the quarter. Financial Gravity Companies Inc.’s holdings in Grifols were worth $282,000....More>>>
Biotech heavyweight Biogen (NASDAQ:BIIB) has now lost over 13% of its value so far this year. To be fair, this year hasn’t been kind to biotechs in general, thanks to President Trump’s aggressive trade policies with China.But Biogen’s value has been declining at a far faster rate than the industry as a whole due to stiffer competition in the all-important multiple sclerosis (MS)....More>>>
It has not been a good year for Gilead Sciences (NSDQ:GILD) shareholders. Gilead stock is down bymore than 25% YTD and almost 30% in last one year. The stock has not only heavily underperformed the broader marketbut has also lagged the sector index iShares NASDAQ Biotech Index ETF (NSDQ:IBB) which is down nearly 17% YTD.The poor performance of the stock is mainly caused by declining HCV sales numbers.....More>>>
Sioux City, IA, based Investment company Security National Bank Of So Dak buys Vanguard S&P 500, Vanguard Energy, iShares Nasdaq Biotechnology Index Fund, Vanguard Health Care, US Bancorp, Vanguard Total World Stock Index, iShares Russell 1000 Value, sells General Electric Co, Qualcomm Inc, Nucor Corp, Westinghouse Air Brake Technologies Corp, Alnylam Pharmaceuticals Inc during the 3-months....More>>>
As concerns about Gilead Sciences (GILD) mount, Maxim’s Jason Kolbert are bullish on the biotech giant’s HIV franchise but not enough to change his Hold rating on the stock:
We recently spoke with GILD management about the launch of Genvoya and other HIV products. Our model now factors in our forecast for patient switch trends from other Gilead products....More>>>
The health care sector has yet to see any significant earnings representation, but that will change this week. In fact, pharmaceutical and biotech investors are about to get a realearnings show, as this week will bring reports from some of the major players, in what is probably the busiest week this earnings season.
24/7 Wall St. has put together a preview of some of the top pharma companies....More>>>
Shares of Novavax, Inc. (NASDAQ:NVAX), a clinical-stage biotech developing vaccines, have risen about 10.7% as of 3:05 p.m. EDT on Thursday. A positive response to the company’s earnings pushed the stock up a couple days ago, but Thursday’s bump comes in response to recent insider share purchases.
Earlier Thursday morning Novavax filed a....More>>>
Shares ofPuma Biotechnology(NASDAQ:PBYI) are up 44% at 12:12 p.m., having been up as much as 84% today, as investors digest the Food and Drug Administration documentsposted ahead of Wednesday’s advisory committee meeting to review the approvability of Puma’s breast cancer drug neratinib.
Today’s jump wasn’t because of surprisingly....More>>>
August 28, 2017: Markets opened higher for the third straight day Monday, but gains were offset in short order on both the S&P 500 and the DJIA. There was no major economic news Monday and no earnings of note. Two large biotech mergers kept the Nasdaq Composite rocking higher. Healthcare and tech posted the largest sector gains will financials and tech stocks lagged. WTI crude oil for October....More>>>
Tel-aviv, L3, based Investment company Clal Insurance Enterprises Holdings Ltd buys iShares Nasdaq Biotechnology Index Fund, Orbotech, Perrigo Co PLC, Amdocs, Ormat Technologies Inc, Tower Semiconductor, MarketAxess Holdings Inc, Kornit Digital, Live Nation Entertainment Inc, Verint Systems Inc, sells Vanguard S&P 500, iShares Russell 2000, iShares U.S. Oil & Gas Exploration & Production,....More>>>
Monday was a good start to the week for stocks, with major benchmarks climbing around half a percent on the day. Most market participants pointed to a lack of bad news over the weekend and anticipation about expected favorable economic data in the coming days as drivers of the generally positive attitude among investors.
But there are still plenty of factors that are preventing stocks overall....More>>>
Editor’s note: Seeking Alpha is proud to welcome Biotech Small-Cap Investor as a new contributor. It’s easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Pro. Click here to find out more 禄
I first took a position in Aveo Pharmaceuticals (AVEO) almost 2 years ago, when the stock was less than....More>>>
Three IPOs raised $363 million in the past week. The two biotechs and a Chinese school operator popped an average of 21%, helping raise the year-to-date average to 8.3%.
Just one company joined the calendar, micro-cap gunshot detector ShotSpotter (Pending:SSTI), and one micro-cap company filed, DJ Basin E&P PetroShare (OTCQB:PRHR). We had expected more JOBS-Act filers this week as Monday....More>>>
We write this introduction early Friday, with the fate of the U.S. House of Representatives vote on the American Health Care Act (AHCA) yet to be determined. While any prediction we utter to the result will look stupid soon enough, we can say that this is surely not going to be the end of political discussions that affect the biotech space. Between the continuation of this legislative process, continued....More>>>